VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
CROX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CROXCrocs, Inc.
$118.09$5.9B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCROXFinancials

Crocs, Inc. (CROX) Income Statement

23Y historyFree accessUpdated daily

Revenue growth stabilized at 2.6% in 2026Q2, with gross margin at 59.4% and operating margin expanding to 24.2% from 15.3% in 2025Q4, though net margin volatility persists due to a one-time $492.3M loss in 2025Q2.

Income StatementBalance SheetCash FlowRatios

CROX Income Statement

Annual statement

CROX Income Statement

Crocs, Inc. (CROX) annual income statement — 23-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03
Sales/Revenue4.05B4.04B4.1B3.96B3.55B2.31B1.39B1.23B1.09B1.02B1.04B1.09B1.2B1.19B1.12B1B789.7M645.77M721.59M847.35M354.73M108.58M13.52M1.17M
Revenue Growth %-2.03%-1.5%3.53%11.46%53.67%66.92%12.62%13.08%6.32%-1.23%-4.98%-8.98%0.46%6.18%12.23%26.75%22.29%-10.51%-14.84%138.87%226.69%703.11%1060.52%-
Cost of Goods Sold1.72B1.74B1.69B1.78B1.69B893.2M636M613.54M528.05M506.29M536.11M579.83M607.88M569.48M515.32M464.49M365.93M337.72M486.72M349.7M154.16M47.77M7.16M891K
COGS % of Revenue-43.03%41.24%45.04%47.67%38.61%45.89%49.86%48.52%49.47%51.73%53.16%50.73%47.75%45.88%46.41%46.34%52.3%67.45%41.27%43.46%44%52.97%76.48%
Gross Profit2.33B2.3B2.41B2.18B1.86B1.42B749.95M617.06M560.15M517.22M500.16M510.81M590.35M623.2M607.98M536.41M423.76M308.05M234.87M497.65M200.57M60.81M6.36M274K
Gross Margin %57.47%56.97%58.76%54.96%52.33%61.39%54.11%50.14%51.48%50.53%48.27%46.84%49.27%52.25%54.12%53.59%53.66%47.7%32.55%58.73%56.54%56%47.03%23.52%
Gross Profit Growth %--4.5%10.68%17.06%30.99%89.38%21.54%10.16%8.3%3.41%-2.08%-13.47%-5.27%2.5%13.34%26.58%37.56%31.16%-52.8%148.12%229.84%856.4%2220.44%-
Operating Expenses1.49B1.41B1.39B1.13B1.01B737.16M535.82M488.41M497.21M494.6M503.17M559.1M565.71M549.15M460.39M404.8M340.05M318.44M413.68M259.88M105.22M33.92M7.93M1.47M
OpEx % of Revenue-35%33.84%28.55%28.4%31.86%38.66%39.69%45.69%48.32%48.56%51.26%47.21%46.04%40.99%40.44%43.06%49.31%57.33%30.67%29.66%31.24%58.65%126.27%
Selling, General & Admin1.49B1.38B1.29B1.11B929.16M715.89M535.82M457.63M447.78M494.6M463.61M515.31M565.71M549.15M460.39M404.8M342.96M311.59M368.8M259.88M105.22M33.92M7.93M1.47M
SG&A % of Revenue-34.27%31.47%28.01%26.14%30.95%38.66%37.19%41.15%48.32%44.74%47.25%47.21%46.04%40.99%40.44%43.43%48.25%51.11%30.67%29.66%31.24%58.65%126.27%
Research & Development029.6M25.6M21.4M18.7M13.7M10.2M00000000000000000
R&D % of Revenue-0.73%0.62%0.54%0.53%0.59%0.74%-----------------
Other Operating Expenses0071.85M061.67M7.56M-10.2M18.97M35.33M-13.4M27.66M53.81M16.64M-15.4M-12M-10.8M-7.8M-855K-6.4M-5.3M-1.8M0-80K0
Operating Income840.58M887.63M1.02B1.05B850.76M683.06M214.12M128.65M62.94M17.34M-6.15M-72.32M-4.73M63.09M146.17M131.08M81.03M-51.18M-188.28M237.77M95.35M26.89M-1.57M-1.2M
Operating Margin %20.73%21.97%24.91%26.41%23.93%29.53%15.45%10.45%5.78%1.69%-0.59%-6.63%-0.39%5.29%13.01%13.1%10.26%-7.93%-26.09%28.06%26.88%24.77%-11.62%-102.75%
Operating Income Growth %--13.14%-2.35%23%24.55%219%66.44%104.39%263.08%381.7%91.49%-1430.34%-107.49%-56.84%11.52%61.76%258.32%72.82%-179.19%149.37%254.55%1811.78%-31.24%-
EBITDA881.85M966.91M1.09B1.1B889.99M715.04M241.74M152.86M92.19M50.47M27.89M-36.33M32.69M104.6M182.87M168.34M118.09M-14.51M-150.83M258.72M103.4M30.23M-871K-1.12M
EBITDA Margin %21.75%23.93%26.61%27.78%25.03%30.91%17.44%12.42%8.47%4.93%2.69%-3.33%2.73%8.77%16.28%16.82%14.95%-2.25%-20.9%30.53%29.15%27.84%-6.44%-96.31%
EBITDA Growth %-18.15%-11.43%-0.82%23.68%24.47%195.79%58.14%65.8%82.69%80.95%176.76%-211.15%-68.75%-42.8%8.63%42.55%913.71%90.38%-158.3%150.21%242.09%3570.26%22.37%-
D&A (Non-Cash Add-back)41.27M79.28M69.84M54.3M39.23M31.98M27.62M24.21M29.25M33.13M34.04M35.99M37.41M41.51M36.69M37.26M37.06M36.67M37.45M20.95M8.05M3.33M700K75K
EBIT846.17M161.26M1.02B1.04B854.67M685.5M213.72M127.96M66.11M19.05M-6.38M-73.78M-7.74M60.98M146.38M137.54M81.45M-47.13M-187.72M237.77M95.35M26.89M-1.57M-1.2M
Net Interest Income-572K-86.44M-105.78M-158.94M-135.14M-20.87M-6.53M-8.04M326K1K-144K-2K858K1.42M860K104K-657K-1.5M-1.79M00000
Interest Income2.06M1.84M3.48M2.41M1.02M775K215K601K1.28M870K692K967K1.66M2.43M1.7M957K00000000
Interest Expense2.63M88.29M109.26M161.35M136.16M21.65M6.74M8.64M955K869K836K969K806K1.02M837K853K657K1.5M1.79M438K567K47K00
Other Income/Expense-81.17M-814.65M-111.33M-170.2M-132.25M-19.21M-7.14M-9.33M2.21M844K-1.06M-2.42M-3.82M-3.14M-626K5.61M-243K2.56M-1.23M2.56M1.28M-603K-66K-3K
Pretax Income759.41M72.98M910.59M876.27M718.51M663.85M206.98M119.32M65.16M18.18M-7.21M-74.74M-8.55M59.96M145.55M136.69M80.79M-48.62M-189.51M240.33M96.63M26.29M-1.64M-1.2M
Pretax Margin %18.73%1.81%22.2%22.12%20.21%28.7%14.93%9.7%5.99%1.78%-0.7%-6.85%-0.71%5.03%12.96%13.66%10.23%-7.53%-26.26%28.36%27.24%24.21%-12.11%-103%
Income Tax165.99M154.18M-39.49M83.71M178.35M-61.84M-105.88M-175K14.72M7.94M9.28M8.45M-3.62M49.54M14.21M23.9M13.07M-6.54M-4.43M72.1M32.21M9.32M-143K0
Effective Tax Rate %21.86%211.26%-4.34%9.55%24.82%-9.32%-51.16%-0.15%22.59%43.69%-128.67%-11.31%42.38%82.62%9.76%17.49%16.17%13.46%2.34%30%33.33%35.44%8.74%0%
Net Income593.42M-81.2M950.07M792.57M540.16M725.69M312.86M119.5M50.44M10.24M-16.49M-83.2M-4.93M10.42M131.34M112.79M67.73M-42.08M-185.08M168.23M64.42M16.97M-1.49M-1.2M
Net Margin %14.63%-2.01%23.16%20%15.19%31.37%22.57%9.71%4.63%1%-1.59%-7.63%-0.41%0.87%11.69%11.27%8.58%-6.52%-25.65%19.85%18.16%15.63%-11.05%-103%
Net Income Growth %150.89%-108.55%19.87%46.73%-25.57%131.95%161.81%136.92%392.64%162.07%80.17%-1588.92%-147.27%-92.07%16.45%66.54%260.95%77.26%-210.02%161.15%279.55%1236.01%-24.5%-
Net Income (Continuing)593.42M-81.2M950.07M792.57M540.16M725.69M312.86M119.5M50.44M10.24M-16.49M-83.2M-4.93M10.42M131.34M112.79M67.73M-42.08M-185.08M168.23M64.42M16.97M-1.49M-1.2M
Discontinued Operations000000000000000000000000
Minority Interest000000000000000000000000
EPS (Diluted)11.83-1.5015.8812.798.7111.394.561.67-1.01-0.07-0.43-1.30-0.220.121.441.240.76-0.49-2.242.000.410.26-0.03-0.01
EPS Growth %209.92%-109.45%24.16%46.84%-23.53%149.78%173.05%265.35%-1342.86%83.72%66.92%-490.91%-283.33%-91.67%16.13%63.16%255.1%78.13%-212%387.8%57.69%958.09%-110.42%-
EPS (Basic)--1.5016.0012.918.8211.624.641.70-1.01-0.07-0.43-1.30-0.220.121.461.270.78-0.49-2.242.080.440.26-0.03-0.01
Diluted Shares Outstanding50.16M54.21M59.83M61.95M62.01M63.72M68.54M71.77M68.42M72.25M73.81M75.39M85.14M86.83M91.21M90.96M87.6M85.11M82.77M84.19M160.34M67.14M49.28M83.42M
Basic Shares Outstanding49.7M54.21M59.38M61.39M61.22M62.46M67.39M70.36M68.42M72.25M73.37M75.39M85.14M86.83M89.96M88.81M85.48M85.11M82.77M80.76M149.2M50.99M49.28M83.42M
Dividend Payout Ratio------------------------

Key Metrics

Growth RegimeMixed
ProfitabilityStable
Balance SheetMixed
Cash FlowStable
Top Statement Risk

Unresolved net margin divergence

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Revenue Growth Stabilizing After Volatility

Crocs' revenue growth has decelerated from 6.2% in 2024Q1 to -1.7% in 2026Q1, but Q2 2026 rebounded to 2.6%, suggesting a potential stabilization. According to the latest quarterly data, the Crocs brand surpassed $1B in quarterly revenue for the first time.

The revenue trajectory shows a clear deceleration from mid-2024 through early 2026, with negative growth in three consecutive quarters (2025Q1-Q3). The 2.6% growth in 2026Q2, driven by a strong beat and record Crocs brand revenue, may indicate a turning point. However, management's guidance for roughly flat Q3 revenue suggests the recovery is not yet broad-based, and the HEYDUDE brand remains a drag. Investors should monitor whether the re-acceleration is sustainable or a one-off driven by innovation and DTC momentum.

Gross Margin Resilience Amid Mix Shifts

Gross margin has remained structurally high, ranging from 54.7% to 61.7% over the past ten quarters, with 2026Q2 at 59.4%. As reported in financial statements, this reflects the low-cost injection-molded production and high-margin Jibbitz accessories, though mix shifts toward HEYDUDE could pressure it.

The gross margin has shown resilience, hovering around 57-59% in recent quarters, with a peak of 61.7% in 2025Q2. This is consistent with the company's moat in Croslite material and the Jibbitz ecosystem, which drives incremental profit. However, the 2025Q4 dip to 54.7% suggests potential mix or input cost pressures. The structural advantage over peers like SHOO (41.1%) and WWW (47.0%) is clear, but any acceleration in HEYDUDE or sneaker sales could compress margins. The recent improvement to 59.4% in 2026Q2 indicates management is managing mix effectively, but sustainability depends on maintaining the core clog's premium pricing.

Operating Leverage Recovering After 2025 Dip

Operating margin expanded from 15.3% in 2025Q4 to 24.2% in 2026Q2, indicating strong operating leverage as SG&A grew slower than revenue. Based on the quarterly data, SG&A as a percentage of revenue fell to 34.6% in 2026Q2 from 39.4% in 2025Q4.

The operating margin has shown a V-shaped recovery, from a low of 15.3% in 2025Q4 to 24.2% in 2026Q2, driven by disciplined SG&A control. In 2026Q2, SG&A grew only 4.2% year-over-year while revenue grew 2.6%, leading to significant operating leverage. This suggests management is effectively scaling overhead, but the 2025Q2 operating margin of 27.0% was higher, indicating there is still room to improve. The key question is whether this leverage can be maintained as the company invests in HEYDUDE turnaround and DTC initiatives.

Net Income Volatility Masks Operating Strength

Net margin swung from -42.8% in 2025Q2 to 17.4% in 2026Q2, driven by a massive one-time loss in 2025Q2. According to the income statement data, the 2025Q2 net loss of $492.3M contrasts sharply with operating income of $310.6M, indicating significant non-operating charges.

The earnings quality is heavily distorted by the 2025Q2 net loss, which appears to be a one-time impairment or write-down, given the operating income was positive. Excluding that quarter, net margins have been stable in the 11-17% range, with 2026Q2 at 17.4% and EPS of $4.12, a 146.7% jump year-over-year. However, the persistent gap between operating margin (22.0%) and net margin (-2.0%) in the most recent trailing twelve months suggests ongoing non-operating drags, likely interest or impairments. Investors should monitor whether these charges are truly one-time or recurring, as they could indicate structural leverage or goodwill impairment risks.

SG&A Efficiency Drives Margin Expansion

SG&A as a percentage of revenue has declined from 39.4% in 2025Q4 to 34.6% in 2026Q2, while COGS as a percentage of revenue improved to 40.6%. As reported in the latest quarterly data, this cost discipline is a key driver of the operating margin recovery.

The cost structure shows a clear focus on SG&A efficiency, with the ratio improving by nearly 500 basis points from the 2025Q4 peak. COGS has also been managed well, with gross margin recovering to 59.4% in 2026Q2 from 54.7% in 2025Q4. This suggests management is effectively controlling both variable and fixed costs, likely through supply chain optimization and DTC mix. However, R&D is reported as zero in most quarters, which may indicate that product innovation is being expensed elsewhere or is not a significant line item. The sustainability of this cost discipline is crucial, especially if resin prices rise or HEYDUDE requires additional investment.

2025Q2: A Pivotal Quarter of Distortion

The 2025Q2 quarter stands out as a major inflection point, with a net loss of $492.3M despite operating income of $310.6M, creating a -42.8% net margin. This quarter likely reflects a significant non-cash impairment or restructuring charge, distorting the income statement trend.

The 2025Q2 quarter is the most critical period in the income statement history, as it marks a dramatic divergence between operating and net profitability. The $492.3M net loss against a $310.6M operating profit suggests a massive one-time charge, possibly related to HEYDUDE goodwill impairment or debt extinguishment. This quarter has lasting impacts on the reported net margin and EPS, making year-over-year comparisons misleading. Investors should adjust for this anomaly to assess underlying profitability, which appears stable. The subsequent recovery in 2026Q2 indicates the company has moved past this event, but the unresolved net margin divergence in the trailing twelve months warrants continued scrutiny.

Net Margin Divergence Raises Red Flags

The persistent gap between operating margin (22.0%) and net margin (-2.0%) in the trailing twelve months suggests significant non-operating costs that could be recurring. According to the latest data, this divergence is a key risk that short-sellers would highlight, as it may indicate hidden leverage or impairment risks.

The most compelling bear case is the unresolved divergence between operating and net margins. While 2025Q2's loss was likely one-time, the trailing twelve-month net margin of -2.0% implies that the company is not generating positive net income despite strong operations. This could be due to high interest expenses from acquisition debt, which the reported Debt/Equity of 1.25% seems to contradict, or recurring impairments. If the debt is actually higher than reported, the company may face refinancing risk in a rising rate environment. Additionally, the HEYDUDE brand's revenue contraction (-1.5% overall) suggests integration challenges that could lead to further write-downs. Investors should demand clarity on the non-operating items before trusting the EPS beat.

CROX — Frequently Asked Questions

Quick answers to the most common questions about buying CROX stock.

What was Crocs, Inc.'s (CROX) revenue in 2025?

For fiscal year 2025, Crocs, Inc. (CROX) reported total revenue of $4.04B. This represents a 346736.7% increase compared to $1.2M in 2003.

Is Crocs, Inc. (CROX) profitable?

Crocs, Inc. (CROX) reported a net loss of $81.2M for the fiscal year ending 2025.

What is Crocs, Inc.'s operating profit margin?

Crocs, Inc. (CROX) reported an operating income of $887.6M, resulting in an operating profit margin of 22.0%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Crocs, Inc.'s gross profit and gross margin?

Crocs, Inc. (CROX) generated $2.30B in gross profit for the year, representing a gross profit margin of 57.0%. This demonstrates the company's core pricing power and production efficiency.